A Randomized, Double-blind, Placebo-controlled, Multiple Ascending Oral Dose Study to Evaulate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Type 2 Diabetic and Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 13 Sep 2013
At a glance
- Drugs DSP 8658 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 16 Sep 2011 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 16 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Jan 2010 New trial record